Study examines the effect of TP53 mutations on outcomes in MDS patients receiving haploidentical haematopoietic stem cell transplantation.

Instead, our data suggest that a mutation in SOCS1 detectable after infusion may have cooperated with CAR activity, CAR vector integration in TP53, or both to contribute to the development of CAR+ ...